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Krüppel-like factors 3 and 8 (KLF3 and KLF8) are highly related transcriptional regulators that bind to similar sequences of
DNA. We have previously shown that in erythroid cells there is a regulatory hierarchy within the KLF family, whereby KLF1
drives the expression of both the Klf3 and Klf8 genes and KLF3 in turn represses Klf8 expression. While the erythroid roles of
KLF1 and KLF3 have been explored, the contribution of KLF8 to this regulatory network has been unknown. To investigate this,
we have generated a mouse model with disrupted KLF8 expression. While these mice are viable, albeit with a reduced life span,
mice lacking both KLF3 and KLF8 die at around embryonic day 14.5 (E14.5), indicative of a genetic interaction between these
two factors. In the fetal liver, Klf3 Klf8 double mutant embryos exhibit greater dysregulation of gene expression than either of
the two single mutants. In particular, we observe derepression of embryonic, but not adult, globin expression. Taken together,
these results suggest that KLF3 and KLF8 have overlapping roles in vivo and participate in the silencing of embryonic globin ex-
pression during development.
Krüppel-like factors (KLFs) are DNA-binding transcriptionalregulators that are involved in a wide range of biological pro-
cesses (1, 2). The defining feature of KLFs is the presence of a
conserved, tandem repeat of three Cys2-His2-type zinc fingers at
their C termini, through which KLFs make sequence-specific con-
tacts with GC-rich and CACCC-related elements of DNA (3–6).
While as a whole this domain is highly conserved within the fam-
ily, specific amino acid differences between the various KLFs result
in different DNA-binding preferences (7). As such, individual
KLFs have been shown to regulate overlapping, but also distinct,
sets of target genes (8, 9). In addition, particular KLFs group to-
gether in their DNA-binding specificities. For instance, KLF1 and
KLF3 recognize similar sequences and hence regulate overlapping
sets of target genes in erythroid cells (8, 10, 11), while KLF4 and
KLF5 together coregulate other genes in stem cells and other tis-
sues (9, –16).
Outside of the DNA-binding domain, KLFs exhibit relatively
little conservation and interact with a range of transcriptional co-
regulators and histone-modifying enzymes (2, 17). Some KLFs,
such as KLF1, primarily function as activators of transcription
(18), while other KLFs, for example KLF3, have typically been
characterized as transcriptional repressors (19). It is also evident
that some KLFs can act as either activators or repressors, depend-
ing on biological context and the gene regulatory region through
which they are operating. This is indeed the case for KLF8 (20–24)
and has also been reported in some instances for KLF1 (25–28)
and KLF3 (29, 30).
KLF1, formerly known as erythroid Krüppel-like factor
(EKLF), is primarily expressed in erythroid cells (18) and is a
master regulator of multiple facets of erythropoietic differentia-
tion (6, 28, 31–37). It is predominantly a transcriptional activator
and binds to CACCC box motifs of the general consensus 5=-CCM
CRC CCN-3= (3, 6). Such motifs are present in the regulatory
regions of many diverse genes but in particular have long been
noted to be essential for the expression of various erythroid genes,
such as those coding for the globins (38). A notable example is the
CACCC box that resides within the promoter of the adult-major
globin (Hbb-b1) gene (3, 6, 18).
Hemoglobin is an oxygen-conveying metalloprotein that is ex-
pressed in erythrocytes and is composed of two -like and two
-like globin peptide chains. Throughout ontogeny, there are dif-
ferent forms of both the -like and -like globins that are ex-
pressed to meet various developmental oxygen demands. This is
known as globin switching, and it accompanies shifting sites of
erythropoiesis during development. For instance, the embryonic
-like globin (Hba-x) and-like globins (Hbb-y and Hbb-bh1) are
expressed in primitive erythroid cells that are transiently pro-
duced in the yolk sac from around embryonic day 7.5 (E7.5) (39,
40). In contrast, the adult globin genes (Hba-a1 and Hbb-b1) are
expressed in definitive cells produced in the fetal liver from
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around E9.5 up until birth, at which point erythropoiesis shifts to
the bone marrow (39). In humans, the -globin locus is subject to
a similar yet distinct mechanism of switching: embryonic ε-globin
is produced by primitive erythroid cells in the yolk sac; fetal -glo-
bin is expressed by definitive cells in the liver until birth, and
transcription of the adult - and -globin genes commences peri-
natally and continues throughout life.
KLF1 plays a crucial role in the switching of -like globins. It
directly binds to the -major globin promoter in vivo and is re-
quired for its transcriptional activity in definitive erythroid cells
(6, 28, 32, 41, 42). Consequently, Klf1 null mice have depleted
levels of -major globin and die at around E15 of severe anemia
(43, 44). Consistent with this, mutations within the orthologous
KLF1-binding site in the human -globin promoter are associated
with -thalassemia (45). In addition to being essential for the
normal expression of adult -globin, KLF1 also plays an indirect
role in the silencing of fetal -globin in human erythroid cells. It
achieves this by driving the expression of BCL11A, an established
repressor of -globin (46–49). Lastly, in addition to its role in
definitive erythroid cells, KLF1 has recently been shown to directly
activate transcription of embryonic globins in primitive erythroid
cells and accordingly, Hbb-y mRNA and Hbb-bh1 mRNA are re-
duced in Klf1/ embryos (50–52).
In addition to globin genes, KLF1 drives the expression of
many genes involved in erythropoietic pathways, such as heme
biosynthesis, cell cycle control, and the establishment of mem-
brane integrity (6, 28, 31–37). KLF1 also activates the transcrip-
tion of two other family members in erythroid cells, Klf3 and Klf8
(10, 11). KLF3 (previously, basic Krüppel-like factor [BKLF]) is a
potent transcriptional repressor that silences gene expression by
recruiting the corepressor C-terminal binding protein (CtBP) (19,
53). KLF3 is expressed widely (29) but in particular is found at
high levels in erythroid tissue owing to an erythroid cell-specific
promoter that is directly activated by KLF1 (6, 10). KLF3 exhibits
similar DNA-binding preferences to KLF1 in vitro (29). Consis-
tent with this, KLF3 represses many genes that are activated by
KLF1 in erythroid cells in vivo and is thought to fine-tune their
expression during erythropoiesis (8). In the absence of KLF3, a set
of genes is abnormally derepressed in mature erythroid cells. This
is thought to explain the multiple erythroid defects of the Klf3 null
mice, namely, reticulocytosis, increased nuclear inclusions (How-
ell-Jolly bodies) in peripheral blood, and mild, compensated ane-
mia (8).
One such gene that is activated by KLF1 and repressed by KLF3
is Klf8 (11). KLF8 is highly related to KLF3, with the two proteins
sharing 96% sequence similarity in their zinc finger domain (54).
They recognize similar sequences of DNA that broadly fit the KLF
DNA-binding consensus 5=-NCN CNC CCN-3= (3, 20, 29).
Moreover, both proteins are able to silence gene expression by
recruiting CtBP corepressors via a conserved Pro-X-Asp-Leu-Ser-
type motif (19, 20). In addition, KLF8 has been shown to activate
transcription from some gene promoters (21–24). KLF8 is not
expressed at readily detectable levels in most cell and tissue types
studied to date (55), but numerous studies have reported its up-
regulation in various human cancers, including prostate (56), gas-
tric (57, 58), hepatocellular (59, 60), glioma (61), breast (62, 63),
renal (64), and ovarian (65). KLF8 has been shown to regulate
oncogenesis by promoting cellular proliferation and tumor inva-
sion and by inhibiting apoptosis (21, 65–68).
Despite a multitude of studies that have investigated the dys-
regulation of KLF8 expression in various cancers, little is known
about its role in normal physiology. Here we report the generation
of the first animal model with a gene trap (gt) insertion in the Klf8
locus and no detectable KLF8 protein. Mice with homozygous
disruption of Klf8 (Klf8gt/gt) are viable but have a shortened life
span. Crossing these mice with Klf3 null mice results in embryonic
lethality, indicative of a genetic interaction between these two fac-
tors. This interaction is pronounced in erythroid tissue, in which
we observe considerable derepression of KLF8 expression in the
absence of KLF3. A cohort of genes is deregulated upon disruption
of this network in fetal liver cells, and in particular, the embryonic
globin genes are derepressed in the absence of both KLF3 and
KLF8.
MATERIALS AND METHODS
Klf3/ and Klf8gt/gt mice. Murine embryonic stem (ES) cells (clone
name AD0101; Sanger Institute Gene Trap Resource) containing a -geo
gene trap cassette in intron 2 of Klf8 were injected into C57BL/6 blasto-
cysts by standard methods in order to generate chimeric mice. Germ line
transmission of the Klf8 gene trap was confirmed, and mice were back-
crossed for at least 10 generations to the FVB/NJ strain. Klf3/mice have
previously been described and were also maintained on a pure FVB/NJ
strain (69). Ethical approval for the use of these mice was obtained from
the Animal Care and Ethics Committees at the University of Sydney (ap-
proval no. L02/6-2006/3/4344 and L02/7-2009/3/5079) and the Univer-
sity of New South Wales (approval no. 09/128A).
Histological examination of mice. Necropsies were conducted on
four wild-type and four litter-matched Klf8gt male mice, ages 12 to 15
weeks (Australian Phenomics Network, The University of Melbourne,
Melbourne, Australia, and IMVS, Adelaide, Australia). A wide range of
organs were sectioned and subjected to standard histological examina-
tion, including heart, liver, spleen, pancreas, kidney, brain, thyroid, tra-
chea, lungs, thymus, skin, testes, epididymis, seminal vesicles, prostate
gland, penis, preputial gland, bladder, gallbladder, stomach, duodenum,
jejunum, ileum, colon, mesenteric lymph node, adrenal glands, tail, eyes,
Harderian glands, spinal cord, salivary glands, and regional lymph nodes.
Paraffin embedding of five Klf3/ Klf8gt/gt and three Klf3/ Klf8gt/gt
E13.5 embryos and subsequent staining with hematoxylin and eosin were
performed by the Histology and Microscopy Unit, University of New
South Wales.
Real-time qRT-PCR. Total RNA from murine tissues was extracted,
DNase treated, and analyzed by real-time quantitative reverse transcrip-
tion (qRT)-PCR as described previously (8, 10, 70). Adult tissues were
from 3- to 4-month-old, sex-matched littermates. The sequences of prim-
ers used are as follows and as listed previously (10): Klf8, 5=-TGGATGTC
CGAATTAAATCAGAAA-3= and 5=-GAAGGATCTCTGGTCGGAACA
G-3= or 5=-CCAAAAGCTCTCACCTGAAAGC-3= and 5=-AGCGAGCAA
ATTTCCAGGAA-3=; εy-globin (Hbb-y), 5=-GGCCTGTGGAGTAAGGT
CAA-3= and 5=-GCAGAGGACAAGTTCCCAAA-3=; h1-globin (Hbb-
bh1), 5=-CTCAAGGAGACCTTTGCTCA-3= and 5=-AATCACCAGCTT
CTGCCAGGC-3=; -major globin (Hbb-b1), 5=-CACTGTGACAAGCTG
CATGT-3= and 5=-TAGTGGTACTTGTGAGCCAG-3=; -globin (Hba-x),
5=-ATGCGGTTAAGAGCATCGAC-3= and 5=-GGGACAGGAGCTTGA
AGTTG-3=; and -globin (Hba-a1), 5=-GTCACGGCAAGAAGGTCG
C-3= and 5=-GGGGTGAAATCGGCAGGGT-3=.
Protein overexpression in COS cells. COS cells were cultured and
transfected as previously described (10) using 1 to 2g pMT3-mKlf8 (11),
pMT2-Klf3 (29), or empty pMT3 vector.
Western blotting. Western blotting of nuclear extracts and the anti-
KLF3 and anti-KLF8 sera have been described previously (11, 29, 71). To
detect KLF8, 0.1% (vol/vol) anti-KLF8 in Tris-buffered saline–Tween 20
(TBST) (50 mM Tris [pH 7.4], 150 mM NaCl, 0.05% Tween 20) with 5%
(wt/vol) skim milk powder was allowed to hybridize with the blot for 12 to
18 h at room temperature. KLF3 was detected using 0.03% anti-KLF3 in
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August 2013 Volume 33 Number 15 mcb.asm.org 2977
 o
n
 O
ctober 26, 2015 by University of Queensland Library
http://m
cb.asm
.org/
D
ow
nloaded from
 
TBST for 1 to 1.5 h. Secondary labeling was achieved using 1:15,000 horse-
radish peroxidase (HRP)-linked anti-rabbit antibody (Amersham Phar-
macia Biotech) in TBST for 1 h at room temperature. Signals were visu-
alized using Immobilon Western chemiluminescent HRP substrate
(Millipore). Blots were stripped in a mixture of 62.5 mM Tris (pH 6.8),
2% SDS, and 0.7% -mercaptoethanol at 70°C for 30 min and were sub-
sequently washed six times with TBST over 30 min. Blots were then re-
blocked and probed using anti--actin (1:10,000) (Sigma) and horserad-
ish peroxidase-linked anti-mouse antibody (1:15,000) (Amersham
Pharmacia Biotech) in TBST, each for 1 h at room temperature.
Determination of the precise genomic location of theKlf8 gene trap.
Confirmation that the gene trap lies within intron 2 of Klf8 was achieved
by RT-PCR analysis of AD0101 ES cells using a forward primer specific for
Klf8 exon 2 (5=-TGGATGTCCGAATTAAATCAGAAA-3=) and reverse
primers specific for the-geo gene trap (5=-AGTATCGGCCTCAGGAAG
ATCG-3= and 5=-ATTCAGGCTGCGCAACTGTTGGG-3=). The precise
site of integration was determined by conducting genomic PCR using
these reverse primers together with 23 forward primers evenly spaced
across the 11.1 kb of intron 2. A single forward primer (5=-GGAACCTG
TGACTGATTTGACTAGGC-3=) yielded a strong PCR band with both of
the reverse primers. Sequencing of the PCR products revealed that the site
of integration lies 434 bp upstream of exon 3.
Genotyping. Genomic DNA was extracted from tail snips or embry-
onic tissue using DirectPCR lysis buffer (Viagen Biotech) as per the man-
ufacturer’s instructions. Klf8 gene trap mice were genotyped by multiplex
PCR using the primer pairs 5=-GGAACCTGTGACTGATTTGACTAGG
C-3= and 5=-GCATTGTGCTAAGTCCACTGACAGC-3=, which flank the
site of gene trap insertion and generate a 210-bp product, indicative of an
intact, wild-type allele, and 5=-CAGTATCTGCAACCTCAAGCTAGCTT
GG-3= and 5=-ATTCAGGCTGCGCAACTGTTGGG-3=, which recognize
the gene trap itself and produce a 348-bp product. PCRs were conducted
using REDTaq DNA polymerase (Roche Molecular Biochemicals) as rec-
ommended by the supplier and in the presence of 10% dimethyl sulfoxide
(DMSO). The following PCR parameters were used: 1 cycle of 94°C for 2
min, 31 cycles of 94°C for 30 s, 60°C for 30 s, and 72°C for 1 min, and 1
cycle of 72°C for 5 min. Klf3 knockout line mice were genotyped as pre-
viously described (69). Klf3 Klf8 double mutant mice were genotyped by
multiplex PCR using the Klf8 primers listed above together with primers
specific for wild-type Klf3 (5=-CATCCTTCCGTCATCGTGCAG-3= and
5=-TTTCAAGTGCGAGCTCTTAGTGTAGACC-3=, 135-bp product)
and for the Klf3 Neo cassette (5=-TCCATGTCTGTCTCCCCCTA-3= and
5=-ATTAAGGGCCAGCTCATTCC-3=, 250-bp product). PCRs were pre-
pared using MangoTaq DNA polymerase (Bioline) as per the manufac-
turer’s instructions and using the following thermocycler parameters: 1
cycle of 94°C for 2 min, 29 cycles of 94°C for 30 s, 60°C for 30 s, and 72°C
for 1 min, and 1 cycle of 72°C for 5 min.
Full blood count analysis. Full blood counts were performed for 21
Klf8 mutant mice (Klf8gt males or Klf8gt/gt females) and 18 wild-type mice
at 11 to 12 weeks of age as previously described (8). For phenylhydrazine
treatment of mice, 7 wild-type and 9 Klf8gt males (18 to 22 weeks of age)
were treated by sequential intraperitoneal injections of 1-acetyl-2-phenyl-
hydrazine (0.5% [wt/vol] in Hanks’ balanced salt solution) at a dose of
0.04 mg per g body mass at time 0 and 16 h. Peripheral blood was collected
by cardiac puncture at 120 h and was subjected to full blood count analysis
as described above.
Sorting of Ter119 erythroid cells. Ter119 cells were sorted from
E13.5, E14.5, and E16.5 fetal livers using mass spectrometry (MS) col-
umns and anti-Ter119 Microbeads (Miltenyi Biotech) as per the suppli-
er’s protocol. Following elution, purified cells were centrifuged for 10 min
at 300 g (4°C), the supernatant was removed, and pellets were harvested
for RNA as described above.
Cytospins of peripheral blood and fetal livers. Peripheral blood and
livers from individual E14.5 embryos were disaggregated in 1 ml filtered
fluorescence-activated cell sorter (FACS) buffer (10 mM EDTA, 5% fetal
calf serum, 0.05% NaN3 in phosphate-buffered saline [PBS]), and cells
were counted using a Countess automated cell counter (Life Technolo-
gies). Cells were diluted to 4	 105/ml in FACS buffer, and 100 to 150 l
was centrifuged for 5 min at 300 rpm in Shandon Cytofunnels (Thermo-
scientific). Slides were subsequently stained using Diff-Quik (Lab Aids,
Pty., Ltd.), and the cells were counted.
ChIP analysis of MEL cells. Murine erythroleukemia (MEL) cells
were cultured and induced to differentiate for 72 h in 1.8% DMSO as
described previously (70). Chromatin immunoprecipitation (ChIP) as-
says were conducted in triplicate as described previously (72, 73), using
rabbit polyclonal anti-KLF3 serum (29) or Pierce anti-KLF3 antibody
(PA5-18030) and preimmune serum or IgG (Santa Cruz sc-2028) as neg-
ative controls. The primer sequences are found elsewhere (11, 50, 74) and
as follows: Hba-a1 promoter, 5=-GTTTGAGGGACTTGCTTCTCTGA-3=
and 5=-GCCCGGACACACTTCTTACC-3=; Hba-x promoter, 5=-AGCCC
ATTGGCACTGAGACT-3= and 5=-CAATCCCTCTTCTGACCTGCTT
A-3=; and Hbb-y promoter, 5=-CATGACCTGGCTCCACCCATGAG-3=
and 5=-CTGCTGCTAGAAGTGGTGGCCTT-3=.
Microarrays. Total RNA was extracted from Ter119 fetal liver cells
purified from four wild-type, four Klf8gt/gt, three Klf3/, and four
Klf3/ Klf8gt/gt embryos (E13.5), litter matched where possible. RNA
was prepared and analyzed by Affymetrix GeneChIP 1.0 ST arrays as pre-
viously described (8). Genes showing a greater than 2-fold change in ex-
pression and passing a false discovery rate (FDR) threshold of 0.3 to cor-
rect for multiple testing were considered to be significantly differentially
expressed.
Microarray data accession numbers. Microarray data have been de-
posited in the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov
/projects/geo) under accession no. GSE43524.
RESULTS
Generation of a Klf8 gene trap mutant mouse model. While a
KLF3 knockout mouse line has been previously characterized and
shown to have mild erythropoietic, adipogenic, and B cell defects
(8, 69, 75, 76), a mutant mouse model for KLF8 has not been
described. Therefore, to investigate the biological role of KLF8, we
generated mice from ES cells (Sanger Institute Gene Trap Re-
source) containing a gene trap (gt) cassette within intron 2 of the
Klf8 gene (Fig. 1A and B). Sequencing of genomic PCRs using a
series of primers spread across Klf8 intron 2 revealed that the
precise site of gene trap integration is 434 bp upstream of exon 3
(Fig. 1C) (data not shown). The gene trap contains a potent splice
acceptor site to disrupt expression of KLF8 and instead generate a
-geo fusion protein. Such splicing was confirmed by RT-PCR
analysis using a forward primer specific for Klf8 exon 2 and reverse
primers specific for the gene trap (data not shown).
While KLF8 protein is normally expressed at very low levels in
noncancerous tissues (55), we have been able to detect endoge-
nous KLF8 in wild-type fetal brain and placental tissue (Fig. 1D
and E). Mice that are homozygous for the gene trap have no de-
tectable KLF8 protein in these tissues (Fig. 1D and E). Similarly,
qRT-PCR analysis of a range of erythroid tissues (E11.5 yolk sac,
E14.5 fetal liver, and adult peripheral blood) revealed that the gene
trap reduced Klf8 mRNA below the level of detection (data not
shown).
The Klf8 gene lies on the X chromosome, and hence males are
hemizygous for the gene trap (Klf8gt), while females can either be
heterozygous (Klf8gt/) or homozygous (Klf8gt/gt). For simplicity,
hemizygous males and homozygous females will be collectively
referred to as Klf8gt/gt throughout. Klf8gt/gt males and females are
both viable and fertile. They have a significantly shortened life
span, with approximately 30% dying by the age of 6 months (P

0.01 and P
 0.001 for males and females, respectively), compared
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to wild-type males and females, who exhibited only 5% and 4%
lethality, respectively, over the same period (Fig. 1f). Heterozy-
gous females exhibited a partially penetrant phenotype, with 16%
of animals dying within 6 months (P 
 0.05 compared to wild-
type females). This might be explained by decreased KLF8 expres-
sion in these animals, the extent of which may vary between indi-
viduals due to nonrandom lyonization (X inactivation).
Necropsies and extensive histological examination of Klf8gt/gt
mice have not yet revealed any phenotypic abnormalities that
might explain the shortened life span of these animals (see Mate-
rials and Methods). Similarly, full blood counts indicated that
erythroid parameters and platelet numbers are normal in Klf8gt/gt
mice (see Fig. S1 in the supplemental material). Moreover, phe-
nylhydrazine treatment did not reveal any significant differences
in blood count parameters between Klf8gt/gt and wild-type mice
(data not shown), suggesting that stress erythropoiesis is not ap-
preciably modulated by KLF8.
Mice lacking both KLF3 and KLF8 are embryonic lethal.
KLF3 and KLF8 are highly related proteins that recognize similar
sequences of DNA, repress transcription via CtBP corepressors,
and are directly upregulated by KLF1 in erythroid cells (11, 19, 20,
29). Given these similarities, we reasoned that they may have over-
lapping physiological roles in vivo and may be able to compensate
functionally for each other’s absence. This hypothesis is made all
the more salient by our previous observation that KLF8 expression
is elevated in Klf3 null mice (8, 11).
Therefore, to explore the possibility of functional redundancy
between these two factors and to elucidate their biological roles,
we crossed the Klf3 knockout (Klf3/) mouse line with the newly
generated Klf8gt/gt line. We have found that Klf3/ mice are es-
sentially infertile, but using a series of different parental crosses
involving Klf3 heterozygous animals, we analyzed the frequency of
the nine possible resulting genotypes (see Fig. S2 in the supple-
mental material) at weaning age (Table 1). The observed numbers
FIG 1 The Klf8 gene trap disrupts normal KLF8 expression and results in increased mortality. (A and B) Schematic of the wild-type (WT) murine Klf8 locus (A)
and the location of the -geo gene trap (B). Klf8 exons are shown as lightly shaded boxes. The gene trap contains a splice acceptor (SA) site, a -galactosidase–
Neomycin resistance fusion gene (-geo), and a poly(A) signal. The -geo fusion protein contains a short (24-amino-acid) N-terminal portion encoded by exon
2 of Klf8. (C) Multiplex genotyping PCRs confirming the integration site of the gene trap in the Klf8 locus. Primer pairs were used that flank the site of gene trap
insertion (210-bp product for a wild-type, intact allele) and that recognize the gene trap (348-bp product). (D) Western blot of KLF8 expression (top panel) in
the fetal brain (E14.5) for the genotypes indicated. KLF8 expressed in COS cells has been included as a positive control, while -actin levels are shown as loading
controls (bottom panel). (E) Western blots of KLF8 (top panel) and-actin (bottom panel) in E10.5 placenta. In panels D and E, the band corresponding to KLF8
is marked with an asterisk. (F) Percentage of animals surviving for the genotypes indicated over a 6-month period. n 40 wild-type males, n 45 Klf8gt males,
n 52 wild-type females, n 87 Klf8gt/ females, and n 16 Klf8gt/gt females. * and ***, P
 0.05 and P
 0.001, respectively, compared to wild-type females;
**, P 
 0.01 compared to wild-type males (log rank tests).
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do not adhere to Mendelian expectance, with no mice observed
that were deficient in both KLF3 and KLF8 (Klf3/ Klf8gt/gt) and
an underrepresentation of female mice containing only a single
allele of Klf8, that is, Klf3/ Klf8gt/ (observed at 10% of the
expected number). Klf3 knockout mice (Klf3/ Klf8/) were
also observed at lower than expected numbers (43% of expected),
in line with a reduced viability of Klf3-deficient animals that we
have previously reported (69). Investigations in utero revealed that
Klf3/ Klf8gt/gt embryos are viable and found at expected Men-
delian numbers at E12.5 (Table 2) but start to die thereafter, with
n  10/15 embryos surviving at E13.5 and n  1/5 surviving at
E14.5. Lethality at this developmental stage is often caused by
cardiovascular defects and/or disrupted liver hematopoiesis (77);
however, histological examination of sections of E13.5 Klf3/
Klf8gt/gt embryos provided no conclusive explanations as to their
cause of death. Taken together, the observation that the Klf8gt/gt
and Klf3/ single-gene mutant mice are viable while the Klf3/
Klf8gt/gt double mutants exhibit an embryonic lethal phenotype
indicates a genetic interaction between KLF3 and KLF8 and sug-
gests that these factors have at least partial functional redundancy
in vivo.
Derepression of KLF8 in Klf3 null erythroid tissue. To fur-
ther investigate the aforementioned repression of the Klf8 gene by
KLF3, we analyzed the levels of Klf8 transcripts in a range of tissues
from Klf3 null mice (Fig. 2A) (data not shown). In all tissues
examined, apart from the brain, we found significant derepression
of Klf8 mRNA. However, despite this derepression, in some tis-
sues, such as the liver and the intestine, the level of Klf8 expression
remains relatively low. In contrast, we found that in erythroid
tissues particularly (that is, the spleen and bone marrow), Klf8 is
expressed at comparatively high levels in the absence of KLF3
(Fig. 2A). This trend is observed not only in adult tissues but also
in embryonic erythroid tissue: KLF8 protein is barely detected in
wild-type and Klf3/ fetal liver but is considerably upregulated in
Klf3 null tissue (Fig. 2B) (11). Taken together, the pronounced
upregulation of Klf8 expression in erythroid tissue is consistent
with our previous observation that the master erythroid regulator
KLF1 directly activates Klf8 transcription in erythroblast cells,
particularly in the absence of KLF3 (11).
Identification of KLF3 and KLF8 target genes in fetal liver.
There is thus a regulatory network within the KLF family in ery-
throid cells, such that KLF1 drives the expression of KLF3 and
KLF8 and KLF3 represses the Klf8 gene. We have previously inves-
tigated the function of KLF3 in this network by microarray anal-
ysis of Klf3 null E14.5 fetal liver cells (8). We next sought to further
unravel the KLF1/KLF3/KLF8 network by analyzing and compar-
ing tissue samples from single mutant (Klf8gt/gt and Klf3/) and
double mutant (Klf3/Klf8gt/gt) animals. As Klf3/Klf8gt/gt em-
bryos die at around E14.5, we analyzed Ter119 (erythroid) fetal
liver cells at E13.5. At this developmental stage, Klf3/ Klf8gt/gt
embryos are largely phenotypically normal (see Fig. S3 in the sup-
plemental material) and their livers display no gross morpholog-
ical abnormalities by histological examination of sections. For this
study, total RNA was extracted from cells from four wild-type,
four Klf8gt/gt, three Klf3/, and four Klf3/ Klf8gt/gt embryos
and was subjected to Affymetrix microarray analysis. In addition,
we confirmed that the Klf8 gene trap ablated KLF8 protein expres-
sion in Klf3/ Klf8gt/gt compared to Klf3/ fetal liver (Fig. 2C).
Comparing Klf8gt/gt embryos with wild-type embryos, there
were very few genes that were significantly deregulated (2-fold;
FDR 
 0.3), and only one of these encoded an annotated mRNA
transcript (H2-Q6; Histocompatibility 2, Q region locus 6) (Fig.
3A). The lack of any considerable gene deregulation in Klf8gt/gt
embryos is not unexpected given that KLF8 protein is not readily
detectable in wild-type fetal liver (Fig. 2B and C).
Next we compared Klf3/ samples with wild-type samples
and observed considerable derepression of gene expression (Fig.
3B; see Fig. S4 and Table S1 in the supplemental material). In total,
64 genes were significantly derepressed, while only 4 genes were
downregulated in the absence of KLF3, consistent with the notion
that KLF3 is primarily a transcriptional repressor in erythroid
cells. These results are highly concordant with our previous mi-
croarrays performed with E14.5 fetal liver cells, with 57 of these 68
genes being significantly deregulated in both studies (see Table
S1). As we had previously observed, Klf8 was one of the most
highly derepressed genes in these cells (10.2-fold) (Fig. 3B; see
Table S1).
Klf3/ Klf8gt/gt cells exhibited even greater deregulation of
gene expression than Klf3/ cells, with 112 genes being up-
regulated and 74 downregulated compared to the wild type
(Fig. 3C and Fig. 4). Strikingly, almost all of the 64 genes that
were derepressed in Klf3/ cells were also significantly dere-
pressed in Klf3/ Klf8gt/gt tissue (see Fig. S4 and Table S1 in
the supplemental material). Only four of the derepressed genes
did not meet these criteria (Frrs1, Cmpk2, Acot9, and Treml2)
but nonetheless displayed upregulation in Klf3/ Klf8gt/gt cells
(between 1.8- and 1.9-fold), albeit not significantly.
The genes that are derepressed in the absence of KLF3 are, by
and large, not further derepressed upon ablation of KLF8 (Fig. 4;
see Fig. S4 and Table S1 in the supplemental material). This sug-
gests that these genes are largely regulated by KLF3 and that KLF8
may play little or no role in their regulation in the absence of KLF3.
Nonetheless, Klf3/ Klf8gt/gt cells did indeed display a greater
TABLE 1 Observed and expected numbers of mice from crosses
between the Klf3/ and Klf8gt/gt linesa
Klf8 genotype
No. of mice (expected, observed) with Klf3
genotype:
/ / /
/ 81, 109 161, 226 81, 35
gt/ 59, 90 118, 154 59, 6
gt/gt 82, 92 165, 175 82, 0
a A total of 887 mice were genotyped at 3 to 4 weeks of age. Klf8gt males and Klf8gt/gt
females have been collectively grouped as Klf8gt/gt, while Klf8 males and Klf8/
females are denoted together as Klf8/. The observed numbers do not adhere to
Mendelian expectance. P 
 0.001, 2 test.
TABLE 2 Observed and expected numbers of embryos from crosses
between the Klf3/ and Klf8gt/gt mouse linesa
Klf8 genotype
No. of embryos (expected, observed) with Klf3
genotype:
/ / /
/ 7, 10 13, 18 7, 5
gt/ 6, 7 12, 9 6, 4
gt/gt 11, 8 22, 21 11, 12
a The counts represent genotyping results from embryos up to E12.5 (n  94). The
observed numbers were not found to significantly deviate from Mendelian expectance.
P  0.61, 2 test.
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deregulation of gene expression than Klf3/ cells (Fig. 3C and
Fig. 4). These additional genes displayed both upregulation and
downregulation consistent with the dual role of KLF8 as both an
activator and a repressor of transcription. These genes represent
potential target genes of KLF8, which KLF8 may redundantly reg-
ulate with KLF3 or which may be uniquely regulated by KLF8.
To identify likely KLF8 candidate target genes, we compared
expression profiles between Klf3/Klf8gt/gt and Klf3/ cells and
compiled a list of 30 significantly differentially expressed genes, 17
of which were upregulated and 13 of which were downregulated
(Fig. 3D; see Fig. S5 in the supplemental material). Notably, sev-
eral of these genes, including Itgb7 (78), Vegfa (79, 80), Periostin
(81), Parm1 (82, 83), Gbp1 (84, 85), Tcfl5 (86, 87), Rps3a (88), and
Fpr1 (89, 90), are regulators of cell adherence, migration, and
invasiveness, consistent with the role of KLF8 in oncogenesis. In
addition, the Klf8 gene itself is significantly downregulated in
Klf3/Klf8gt/gt compared to Klf3/ cells, as anticipated (Fig. 3D;
see Fig. S5).
Embryonic globin genes are derepressed in the absence of
KLF3 and KLF8. The most highly upregulated gene within this list
was that encoding Hbb-bh1 (3.8-fold), an embryonic -globin
(Fig. 3D). This was of interest given that KLF1 plays a crucial role
in the activation of adult -globin and the silencing of embryonic
and fetal globins in definitive erythroid cells. This raised the pos-
sibility of an elegant system whereby KLF1 drives adult -globin
and also upregulates KLF3 and KLF8, which then function to re-
press the expression of embryonic globins. Indeed, inspection of
globin gene expression in Klf3/ Klf8gt/gt cells compared to
Klf3/ cells revealed that the other murine embryonic genes,
Hba-x and Hbb-y, are elevated 2.8-fold and 1.5-fold, respectively
(Fig. 3D), while the adult globin genes, Hbb-b1 and Hba-a1, are
unaltered.
We next sought to validate the derepression of embryonic glo-
bins by qRT-PCR analysis of Ter119 E13.5 fetal liver cell samples
independently purified from those used in the arrays. We consis-
tently observed significant upregulation of all three embryonic
globin genes in Klf3/ cells compared to wild-type cells (4.07-,
2.66-, and 1.62-fold, respectively, for Hba-x, Hbb-y, and Hbb-bh1)
(Fig. 5A to C). We also tested the hypothesis that these embryonic
globin genes are further derepressed in Klf3/ Klf8gt/gt cells and
found this to be the case (1.60-, 1.68-, and 1.67-fold, respectively,
compared to Klf3/; P 0.04, P 0.07, and P 0.03, one-tailed
t tests) (Fig. 5A to C). Adult globin expression was unaffected in
both Klf3/ and Klf3/ Klf8gt/gt cells compared to wild-type
cells (Fig. 5D and E).
The embryonic lethality of Klf3/ Klf8gt/gt mice precluded
analysis of later developmental stages; however, examination of
Klf3/ cells revealed elevated expression of embryonic but not
adult globins at both E14.5 (see Fig. S6 in the supplemental
material) and E16.5 (see Fig. S7 in the supplemental material).
Cytospins of peripheral blood and fetal liver tissue at E14.5
revealed no difference in the numbers of primitive erythrocytes
between wild-type and Klf3/ animals that might explain the
elevated expression of embryonic globins (see Fig. S8 in the
supplemental material). Furthermore, we observed no deregu-
lation of either embryonic or adult globin expression in
Klf3/ E10.5 yolk sac, a source of primitive erythroid cells (see
Fig. S9A to E in the supplemental material). Similarly, both
embryonic and adult globin transcript levels were comparable
in Klf3/ Klf8gt/gt and litter-matched Klf3/ Klf8gt/gt yolk
sacs (see Fig. S9F to J). Taken together, these results suggest
that KLF3 in particular, represses the expression of the embry-
onic globin genes in definitive erythroid cells and that KLF8
partially compensates in its absence.
FIG 2 Klf8 expression is elevated in erythroid tissue in the absence of KLF3. (A) Klf8 transcript levels were quantified by real-time RT-PCR in whole tissues from
adult wild-type (WT; n 3) and Klf3/ (Klf3 KO; n 3) mice. Expression has been normalized to 18S rRNA levels, and the lowest level (wild-type liver) has
been set to 1.0. Error bars represent standard errors of the mean. *, P
 0.04 (two-tailed t test for Klf3/ compared to wild type). (B and C) Western blots of E14.5
(B) and E13.5 (C) fetal liver nuclear extracts using anti-KLF8 (KLF8), anti-KLF3 (KLF3), and anti--actin sera. Genotypes are indicated, and nuclear extracts
from COS cells (mock transfected or overexpressing KLF3 or KLF8) have been included as controls. In panel C, the band corresponding to KLF8 is marked with
an asterisk.
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Other KLFs, namely, KLF1 and KLF2, have previously been
shown to directly bind to the promoters of the embryonic globin
genes in erythroid cells (50, 52). To explore the possibility that
KLF3 represses embryonic globin expression by a similar mecha-
nism, we conducted chromatin immunoprecipitation (ChIP)
studies using differentiated MEL cells. These erythroid cells rou-
tinely yield robust immunoprecipitation using antibodies for
KLF3, as evidenced by significant enrichment at a positive-control
region (Klf8 promoter 1a) (8, 11) (Fig. 6). We observed no enrich-
ment at the promoters of the embryonic globin genes (Hba-x and
Hbb-y), but unexpectedly, we found significant KLF3 occupancy
at the promoters of the adult globin genes, particularly at Hba-a1
and to a lesser extent at Hbb-b1. We also observed significant
binding at upstream DNase-hypersensitive sites (HS26 and HS2)
known to play a role in the regulation of the - and -globin loci,
respectively. These data raise the possibility that KLF3 influences
embryonic globin gene expression not by direct binding to their
promoters but through distal sites within the globin loci.
DISCUSSION
Deregulation of KLF8 has been observed in a wide variety of can-
cers; however, the normal physiological roles of this transcription
factor have remained largely unknown. To this end, we have gen-
erated a mouse line with disrupted KLF8 expression. Klf8gt/gt mice
are viable and fertile but have a shortened life span, the cause of
which could not be identified despite extensive histological char-
acterization. Mice that are deficient in the related family member
KLF3 are also viable, yet Klf3/ Klf8gt/gt double mutant animals
die at around E14.5. This suggests that KLF3 and KLF8 have over-
lapping roles in vivo and can at least partially compensate in each
other’s absence.
Analysis of Klf3/ mice revealed marked upregulation of
KLF8 expression in several tissues, but particularly erythroid tis-
sue. Given that both the Klf3 and Klf8 genes are activated by the
erythroid factor KLF1, we hypothesized that these three factors
operate in a regulatory network to control gene expression. Mi-
croarray analysis of Ter119 fetal liver cells from single mutant
FIG3 Volcano plots demonstrating gene expression changes in Klf8gt/gt, Klf3/, and Klf3/Klf8gt/gt Ter119E13.5 fetal liver cells. (A) Klf8gt/gt versus wild type
(WT). (B) Klf3/ versus WT. (C) Klf3/ Klf8gt/gt versus WT. (D) Klf3/ Klf8gt/gt versus Klf3/. Significance thresholds are shown (2-fold deregulation,
FDR
 0.3), and significantly deregulated genes are represented by red dots (derepressed relative to WT [A to C] or Klf3/ [D]) or green dots (downregulated
relative to WT [A to C] or Klf3/ [D]).
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(Klf3/ and Klf8gt/gt) and double mutant (Klf3/ Klf8gt/gt) em-
bryos revealed that this was indeed the case. We observed more
extensive deregulation of gene expression in Klf3/ Klf8gt/gt cells
compared to either of the single knockouts. It appears that KLF3
plays a somewhat nonredundant role in this network in that 64
genes are upregulated in the absence of KLF3 alone, and these are
not further significantly elevated in Klf3/ Klf8gt/gt embryos.
Klf3/ Klf8gt/gt embryos did, however, display greater dysregula-
tion of gene expression than Klf3/ embryos, with 186 genes
being significantly differentially expressed relative to the wild type.
These genes were both up- and downregulated, consistent with
the dual role of KLF8 as both an activator and a repressor of tran-
scription. By comparing Klf3/ Klf8gt/gt gene expression profiles
FIG 4 Heat map showing the relative expression of the genes that are dereg-
ulated in Klf3/ Klf8gt/gt Ter119 E13.5 fetal liver cells compared to the wild
type (WT). Genes that are significantly upregulated (group I) and downregu-
lated (group II) in Klf3/ Klf8gt/gt cells are represented, and their relative
expression across the four genotypes (wild type, Klf8gt/gt, Klf3/, and Klf3/
Klf8gt/gt) is shown.
FIG 5 Embryonic, but not adult, globin genes are derepressed in Klf3/ and Klf3/ Klf8gt/gt Ter119 E13.5 fetal liver cells. Transcript levels for Hba-x (A),
Hbb-y (B), Hbb-bh1 (C), Hba-a1 (D), and Hbb-b1 (E) were determined by qRT-PCR analysis of total RNA from three wild-type (WT), five Klf3/, seven
Klf8gt/gt, and four Klf3/ Klf8gt/gt embryos. Embryonic globin genes are shown in light gray, and adult globin genes are in dark gray. Expression has been
normalized to 18S rRNA levels, and wild-type samples have been set to 1.0 for each gene. Error bars indicate standard errors of the mean. *, P 0.05 (two-tailed
t test compared to wild type).
FIG 6 Chromatin immunoprecipitation analysis of KLF3 occupancy at -
and -globin loci in induced MEL cells. ChIP assays were conducted in tripli-
cate, and enrichment has been determined by quantitative real-time PCR and
has been normalized to input. The lowest values for both IgG and anti-KLF3
have been set to 1.0. Klf8 promoter 1a has been included as a positive control.
Error bars represent standard errors of the mean. *, P 
 0.05; **, P 
 0.005
(one-tailed t test compared to IgG). HS, DNase-hypersensitive site.
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with Klf3/, we refined a list of the most likely KLF8 targets.
Included in this list were several genes involved in cell cycle regu-
lation, adherence, and invasiveness, in agreement with the role of
KLF8 in oncogenesis.
We also confirmed by qRT-PCR that embryonic globin expres-
sion is derepressed in Klf3/ and Klf3/ Klf8gt/gt cells, while
adult globin expression is unchanged. This was observed not only
at E13.5 but also at later stages of fetal liver development (E14.5
and E16.5) in Klf3/ embryos. The simplest interpretation of
these results is that KLF3, which is highly expressed in fetal liver, is
the primary repressor of embryonic globin expression, but in its
absence, KLF8 is able to partially compensate. While the effects on
embryonic globin expression are indeed modest, we suggest that
KLF3 and KLF8 together participate in the silencing of embryonic
globins with other proposed repressors, such as SOX6, GATA1,
YY1, COUP-TF, and DRED (91–94). The expression levels of
these repressors were not significantly altered in the microarrays
presented here in either Klf3/ or Klf3/ Klf8gt/gt cells (all less
than 1.12- and 1.35-fold, respectively, compared to the wild type).
Similarly, the expression of BCL11A, a transcriptional repressor of
the murine embryonic and human fetal globin genes (48, 49), was
found to be unchanged in Klf3/ and Klf3/ Klf8gt/gt cells com-
pared to the wild type. Together, this suggests that the repression
of embryonic globin genes by KLF3 and KLF8 is not indirectly
achieved by altering the transcription of these known regulators in
erythroid cells.
Interestingly, an analogous system of embryonic globin gene
regulation and functional compensation has been observed for the
activator KLFs, KLF1 and KLF2. The Klf1/ and Klf2/ single
knockout mice die at around E14.5 and E12.5 to E14.5, respec-
tively, whereas Klf1/ Klf2/ double knockout animals die be-
fore E11.5 (43, 44, 95–97). Expression of the -like embryonic
globins (Hbb-y and Hbb-bh1) is significantly reduced in the prim-
itive erythroid cells of both Klf1/ and Klf2/ single knockout
embryos (50, 51, 98) and is further depleted in Klf1/ Klf2/
double knockout embryos (97). Thus, in primitive erythroid cells,
KLF1 and KLF2 drive transcription of embryonic globin genes,
while in definitive erythroid cells, KLF3 and KLF8 serve to repress
embryonic globin expression.
In addition to the -like embryonic globins, we also observed
upregulated Hba-x expression in Klf3/ and Klf3/ Klf8gt/gt fe-
tal liver cells. The Hba-x gene has a functional CACCC box in its
promoter (99) and like Hbb-y and Hbb-bh1 is also downregulated
in Klf1/ and Klf1/Klf2/ embryos (97). Hba-x expression is
also strongly upregulated, more so than Hbb-y and Hbb-bh1, upon
inducible restoration of KLF1 activity induced in Klf1/ eryth-
roblast cells (32). Taken together, these results implicate the KLFs
in the regulation of the -globin locus in addition to the -globin
locus.
The concomitant upregulation of both -like and -like em-
bryonic globin genes has also been observed in other mouse mod-
els. Perhaps the best characterized repressor of embryonic globin
expression is the SOX6 transcription factor (100). SOX6 directly
binds to the Hbb-y promoter and silences its expression in defin-
itive erythroid cells. As such, mice lacking SOX6 exhibit persistent
expression of Hbb-y in the fetal liver. In addition, Hba-x and Hbb-
bh1 transcript levels are also considerably elevated in Sox6/ fetal
liver cells, albeit not to the same extent (100). Thus, the coinciding
deregulation of embryonic globin genes is a feature that is shared
by the KLF3/8, KLF1/2, and SOX6 mouse models.
It is likely that this network of cross-regulation and functional
compensation within the KLF family serves to fine-tune the ex-
pression of globin genes and other genes during development.
Such regulatory circuitries have indeed been identified for other
transcription factor families, such as the myogenic basic helix-
loop-helix factors (MYOD, MYF5, myogenin, and MRF4) and the
paired box (PAX) factors. These families are subject to transcrip-
tional cross-regulation, and family members display overlapping
physiological roles, such that single factor knockouts often exhibit
mild or no phenotype, while combinatorial knockouts can result
in severe physiological perturbations (101, 102). Correct temporal
expression of globins is thus likely to be sensitive to the levels of
both activating and repressing KLFs. Indeed a dose effect has pre-
viously been observed for both KLF1 and KLF2. Hbb-y and Hbb-
bh1 are both downregulated in Klf2/ primitive erythroid cells
compared to wild-type cells (98), while Klf1/ fetal livers show a
reduction in -globin transcript levels (103). In addition, haplo-
insufficiency of KLF1 results in delayed globin switching (103,
104), while overexpression of KLF1 causes premature switching
(105).
The network discussed here, in which KLF1 activates the ex-
pression of Klf3 and Klf8, while KLF3 represses Klf8, is known as
an incoherent type 1 feed forward network. Such networks are
able to effect transient pulses in expression of their target genes
and can accelerate the response of these genes to upstream signal-
ing (106). They can also serve to sensitize transcriptional pro-
grams to various amplitudes of input signals from external stimuli
(107). From the work presented here and previously (8, 32, 33,
36), it is evident that disruption of the KLF1/KLF3/KLF8 network,
by removal of single factors or combinations thereof, results in
altered transcriptional profiles, suggesting that the network oper-
ates to ensure the correct developmental control of gene expres-
sion required for normal erythropoiesis.
Lastly, it should be noted that although KLF1 and KLF2 have
both been shown to directly bind to the promoters of the embry-
onic globin genes, we have thus far not detected KLF3 occupancy
at these sites (Fig. 6). Unexpectedly, we observed binding at the
promoters of the adult globin genes and also at upstream DNase-
hypersensitive sites. The mechanism by which KLF3 regulates glo-
bin expression thus remains unclear and may involve distal bind-
ing and the formation or disruption of long-range interactions, as
has been shown to be the case for BCL11A (48, 108). Alternatively,
it is possible that KLF3 does bind the proximal promoter CACCC
boxes of the embryonic globin genes during a particular window
of development or stage of cellular maturation that we have not
yet examined.
Taken together, these results establish KLF3 and KLF8 as a pair
of transcriptional regulators that operate in an erythroid tran-
scriptional network downstream of KLF1. Of these two factors,
KLF3 plays the dominant role in regulating gene expression owing
to its comparatively higher abundance. KLF8 is able to partially
compensate at some loci, however, and indeed ablation of both
KLF3 and KLF8 results in more widespread gene dysregulation
than knockout of KLF3 alone. Among the most significantly af-
fected genes, we identified the embryonic globin genes, suggesting
that KLF3 and KLF8 participate in their developmental silencing
together with other repressors, such as SOX6, GATA1, YY1,
COUP-TF, and DRED. Thus, in addition to BCL11A, KLF3 and
KLF8 represent two examples of transcriptional repressors down-
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stream of KLF1 that cooperate to achieve normal globin regula-
tion during ontogeny.
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